| Literature DB >> 27600690 |
Massimo F Piepoli1, Ugo Corrà2, Paul Dendale3, Ines Frederix4, Eva Prescott5, Jean Paul Schmid6, Margaret Cupples7, Christi Deaton8, Patrick Doherty9, Pantaleo Giannuzzi2, Ian Graham10, Tina Birgitte Hansen11, Catriona Jennings12, Ulf Landmesser13, Pedro Marques-Vidal14, Christiaan Vrints15, David Walker16, Héctor Bueno17, Donna Fitzsimons18, Antonio Pelliccia19.
Abstract
Worldwide, each year more than 7 million people experience myocardial infarction, in which one-year mortality rates are now in the range of 10%, but vary with patient characteristics. The consequences are even more dramatic: among patients who survive, 20% suffer a second cardiovascular event in the first year and approximately 50% of major coronary events occur in those with a previous hospital discharge diagnosis of ischaemic heart disease. The people behind these numbers spur this call for action. Prevention after myocardial infarction is crucial to reduce risk and suffering. Evidence-based interventions include optimal medical treatment with anti-platelets and statins, achievement of blood pressure, lipid and blood glucose targets, and appropriate lifestyle changes. The European Society of Cardiology and its constituent bodies are determined to embrace this challenge by developing a consensus document in which the existing gaps for secondary prevention strategies are reviewed. Effective interventions in relation to the patients, healthcare providers and healthcare systems are proposed and discussed. Finally, innovative strategies in hospital as well as in outpatient and long-term settings are endorsed.Entities:
Keywords: Cardiovascular prevention; cardiac rehabilitation; exercise training; healthcare systems; myocardial infarction; pharmacological therapy; risk factors
Mesh:
Year: 2016 PMID: 27600690 DOI: 10.1177/2047487316663873
Source DB: PubMed Journal: Eur J Prev Cardiol ISSN: 2047-4873 Impact factor: 7.804